LiNA Medical Innovation ApS: Financial statements 2017
CVR: 36015535
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
LiNA Medical Innovation ApS (CVR 36015535) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -3,433 compared with DKK 1,934 the year before. Equity in the 2017 report amounted to DKK 36,671. The solvency ratio was 86.7%.
- Profit/Loss
- DKK -3,433
- Equity
- DKK 36,671
- Total Assets
- DKK 42,281
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -3K | 37K | - |
| 2016 | - | - | 2K | 40K | - |
| 2015 | - | -11K | -12K | 38K | - |
Official annual report
Keep an eye on LiNA Medical Innovation ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
On May 30, 2017, the company changed its name from EPPING ApS to LiNA Medical Innovation ApS.
About LiNA Medical Innovation ApS
LiNA Medical Innovation ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2014. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named EPPING ApS. The management consists of Niels Søren Frederik Kornerup. The company is owned by LiNA WW Holding AG. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a net result of DKK -61,343 compared with DKK -13,822 the year before. Equity in the 2026 report amounted to DKK -89,822.
